| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 6 | 2016 | 520 | 1.440 |
Why?
|
| Echocardiography, Doppler | 3 | 2020 | 187 | 0.840 |
Why?
|
| Aorta | 2 | 2016 | 666 | 0.780 |
Why?
|
| Heart Atria | 3 | 2020 | 346 | 0.680 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2017 | 166 | 0.630 |
Why?
|
| Echocardiography | 12 | 2022 | 1219 | 0.630 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2017 | 15 | 0.570 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2017 | 18 | 0.570 |
Why?
|
| Heart Ventricles | 6 | 2022 | 837 | 0.560 |
Why?
|
| Heart Septal Defects, Ventricular | 5 | 2018 | 136 | 0.560 |
Why?
|
| Heart Aneurysm | 1 | 2016 | 40 | 0.550 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 102 | 0.550 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2016 | 107 | 0.520 |
Why?
|
| Tetralogy of Fallot | 3 | 2015 | 163 | 0.510 |
Why?
|
| Carotid Artery, Internal | 1 | 2015 | 81 | 0.480 |
Why?
|
| Heart Diseases | 2 | 2020 | 722 | 0.460 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 364 | 0.430 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2022 | 402 | 0.420 |
Why?
|
| Cyanosis | 2 | 2015 | 43 | 0.410 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 463 | 0.400 |
Why?
|
| Heart Defects, Congenital | 7 | 2015 | 1796 | 0.380 |
Why?
|
| Mass Screening | 1 | 2017 | 1547 | 0.310 |
Why?
|
| Pulmonary Atresia | 1 | 2007 | 48 | 0.290 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2007 | 67 | 0.280 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2005 | 219 | 0.280 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2007 | 101 | 0.270 |
Why?
|
| Heart Neoplasms | 1 | 2008 | 209 | 0.260 |
Why?
|
| Leg | 1 | 2007 | 217 | 0.260 |
Why?
|
| Mitral Valve | 1 | 2007 | 265 | 0.260 |
Why?
|
| Venae Cavae | 1 | 2005 | 14 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2008 | 7916 | 0.250 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 30 | 0.250 |
Why?
|
| Coronary Aneurysm | 1 | 2005 | 35 | 0.250 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2005 | 128 | 0.240 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2007 | 253 | 0.230 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 76 | 0.230 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2018 | 923 | 0.220 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2007 | 265 | 0.220 |
Why?
|
| Pulmonary Veins | 1 | 2005 | 181 | 0.220 |
Why?
|
| Coronary Vessels | 1 | 2007 | 606 | 0.210 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 291 | 0.210 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2002 | 5 | 0.210 |
Why?
|
| Anorexia Nervosa | 1 | 2002 | 30 | 0.210 |
Why?
|
| Infant | 14 | 2021 | 13994 | 0.210 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2008 | 1068 | 0.190 |
Why?
|
| Ventricular Function, Right | 1 | 2022 | 116 | 0.190 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2004 | 342 | 0.180 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 548 | 0.180 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 1023 | 0.180 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 28 | 0.180 |
Why?
|
| Esophagogastric Junction | 1 | 2004 | 558 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 4054 | 0.170 |
Why?
|
| Heart Failure | 3 | 2007 | 2330 | 0.170 |
Why?
|
| Humans | 38 | 2022 | 270713 | 0.160 |
Why?
|
| Myocarditis | 1 | 2021 | 177 | 0.160 |
Why?
|
| Anthracyclines | 1 | 2020 | 339 | 0.150 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 15275 | 0.150 |
Why?
|
| Kidney | 1 | 2007 | 2102 | 0.150 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 125 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2017 | 85 | 0.150 |
Why?
|
| Acarbose | 1 | 2017 | 3 | 0.140 |
Why?
|
| Glucosidases | 1 | 2017 | 3 | 0.140 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2017 | 4 | 0.140 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2016 | 1 | 0.140 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 741 | 0.140 |
Why?
|
| Noonan Syndrome | 1 | 2016 | 29 | 0.140 |
Why?
|
| Protein Phosphatase 1 | 1 | 2016 | 79 | 0.140 |
Why?
|
| Ultrasonography | 4 | 2007 | 1931 | 0.140 |
Why?
|
| Male | 23 | 2021 | 128479 | 0.130 |
Why?
|
| Child, Preschool | 11 | 2021 | 17072 | 0.130 |
Why?
|
| Adolescent | 13 | 2021 | 32689 | 0.130 |
Why?
|
| Transposition of Great Vessels | 3 | 2005 | 133 | 0.130 |
Why?
|
| Infant, Newborn | 8 | 2021 | 8603 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2021 | 1233 | 0.120 |
Why?
|
| Peripheral Nerves | 1 | 1995 | 159 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 247 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 1995 | 247 | 0.110 |
Why?
|
| Point Mutation | 1 | 2016 | 785 | 0.110 |
Why?
|
| Ethics Committees | 1 | 1993 | 4 | 0.110 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1999 | 526 | 0.110 |
Why?
|
| Ethics | 1 | 1993 | 27 | 0.110 |
Why?
|
| Cancer Survivors | 1 | 2020 | 746 | 0.110 |
Why?
|
| Female | 17 | 2021 | 148885 | 0.100 |
Why?
|
| Angiography | 2 | 2005 | 349 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 4838 | 0.100 |
Why?
|
| Ethics Consultation | 1 | 1993 | 36 | 0.100 |
Why?
|
| Professional Role | 1 | 1993 | 75 | 0.100 |
Why?
|
| Ethicists | 1 | 1993 | 43 | 0.100 |
Why?
|
| Child | 13 | 2022 | 30560 | 0.100 |
Why?
|
| Professional Competence | 1 | 1993 | 138 | 0.100 |
Why?
|
| Hospitalization | 1 | 2021 | 2170 | 0.100 |
Why?
|
| Radiography | 2 | 2015 | 1994 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1995 | 407 | 0.100 |
Why?
|
| Sarcoma, Ewing | 1 | 1995 | 428 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2008 | 16741 | 0.090 |
Why?
|
| Pregnancy | 3 | 2018 | 7916 | 0.090 |
Why?
|
| Treatment Outcome | 7 | 2020 | 33847 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 1995 | 671 | 0.080 |
Why?
|
| Brain | 1 | 2002 | 4202 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 1995 | 1476 | 0.070 |
Why?
|
| Computer Systems | 1 | 2007 | 113 | 0.070 |
Why?
|
| Adult | 8 | 2018 | 82041 | 0.070 |
Why?
|
| Hydronephrosis | 1 | 2007 | 51 | 0.070 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 88 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 200 | 0.060 |
Why?
|
| Heart Murmurs | 1 | 2005 | 15 | 0.060 |
Why?
|
| Tachycardia, Sinus | 1 | 2005 | 12 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2006 | 150 | 0.060 |
Why?
|
| Tricuspid Atresia | 1 | 2005 | 14 | 0.060 |
Why?
|
| Neoplasms | 2 | 2022 | 15949 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2008 | 377 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 4966 | 0.060 |
Why?
|
| Prognosis | 2 | 2017 | 22528 | 0.060 |
Why?
|
| Long-Term Care | 1 | 2005 | 85 | 0.060 |
Why?
|
| Pelvis | 1 | 2007 | 381 | 0.060 |
Why?
|
| Electrocardiography | 3 | 2005 | 1146 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2005 | 124 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2005 | 192 | 0.060 |
Why?
|
| Warfarin | 1 | 2005 | 145 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1381 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 327 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2005 | 370 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2003 | 72 | 0.050 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2002 | 31 | 0.050 |
Why?
|
| Evoked Potentials, Visual | 1 | 2002 | 39 | 0.050 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2003 | 70 | 0.050 |
Why?
|
| Aspirin | 1 | 2005 | 373 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2006 | 501 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 211 | 0.050 |
Why?
|
| Evoked Potentials, Motor | 1 | 2002 | 60 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2022 | 39959 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 99 | 0.050 |
Why?
|
| Fever | 1 | 2005 | 517 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2006 | 448 | 0.050 |
Why?
|
| Systole | 1 | 2022 | 217 | 0.050 |
Why?
|
| Spine | 1 | 2003 | 312 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2003 | 287 | 0.050 |
Why?
|
| Myocardium | 1 | 2006 | 1180 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 550 | 0.040 |
Why?
|
| Cineangiography | 1 | 1999 | 17 | 0.040 |
Why?
|
| Acute Disease | 2 | 2021 | 2492 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2021 | 244 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 563 | 0.040 |
Why?
|
| Young Adult | 1 | 2017 | 22243 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2018 | 121 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1999 | 145 | 0.040 |
Why?
|
| Mutation | 1 | 2017 | 15917 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 2051 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 7648 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 1999 | 537 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 1149 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2008 | 6766 | 0.030 |
Why?
|
| Gestational Age | 1 | 1999 | 1160 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 818 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1995 | 261 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1999 | 618 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 1999 | 605 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1997 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 2258 | 0.030 |
Why?
|
| Democracy | 1 | 1993 | 2 | 0.030 |
Why?
|
| Social Dominance | 1 | 1993 | 16 | 0.030 |
Why?
|
| Freedom | 1 | 1993 | 19 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 14033 | 0.030 |
Why?
|
| Education | 1 | 1993 | 125 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 4394 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 6193 | 0.020 |
Why?
|
| Age Factors | 3 | 2008 | 5441 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 1993 | 210 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1993 | 207 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 1993 | 273 | 0.020 |
Why?
|
| Incidence | 1 | 2021 | 5825 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 6233 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 4494 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 5157 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1995 | 2856 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 3606 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 1995 | 4020 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 12978 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 6502 | 0.020 |
Why?
|
| Troponin | 1 | 2006 | 85 | 0.020 |
Why?
|
| Decision Making | 1 | 1993 | 1249 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9463 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 1307 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2006 | 312 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 9053 | 0.010 |
Why?
|
| United States | 1 | 2021 | 15828 | 0.010 |
Why?
|
| Angiocardiography | 1 | 2002 | 15 | 0.010 |
Why?
|
| Reoperation | 1 | 2008 | 1389 | 0.010 |
Why?
|
| Tachycardia | 1 | 2003 | 84 | 0.010 |
Why?
|
| Heart Bypass, Right | 1 | 2002 | 17 | 0.010 |
Why?
|
| Aortic Coarctation | 1 | 2004 | 105 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2003 | 164 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 265 | 0.010 |
Why?
|
| Hypotension | 1 | 2003 | 225 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2006 | 13419 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 906 | 0.010 |
Why?
|
| Heart Rate | 1 | 2003 | 744 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 1999 | 44 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2002 | 675 | 0.010 |
Why?
|
| Retreatment | 1 | 1999 | 449 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 1691 | 0.010 |
Why?
|
| Equipment Design | 1 | 1999 | 1207 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12530 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2008 | 5674 | 0.010 |
Why?
|
| Palliative Care | 1 | 2004 | 2176 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 17861 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 73613 | 0.000 |
Why?
|